Gene interaction map: a paradigm for identifying significant pathways responsible for rheumatoid arthritis

[1]  Guang-Yaw Liu,et al.  Functional Roles of the Non-Catalytic Calcium-Binding Sites in the N-Terminal Domain of Human Peptidylarginine Deiminase 4 , 2013, PloS one.

[2]  Teresa M. Przytycka,et al.  Chapter 5: Network Biology Approach to Complex Diseases , 2012, PLoS Comput. Biol..

[3]  J. Dean,et al.  The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look , 2012, The open rheumatology journal.

[4]  L. Tourneur,et al.  Fas-associated death domain protein and adenosine partnership: fad in RA. , 2012, Rheumatology.

[5]  E. Karlson,et al.  Environmental and gene-environment interactions and risk of rheumatoid arthritis. , 2012, Rheumatic diseases clinics of North America.

[6]  G. Peters,et al.  Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis , 2012, Journal of Pharmacology and Experimental Therapeutics.

[7]  Xin Yu,et al.  Immune Complex-Mediated Cell Activation from Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients Elaborate Different Requirements for IRAK1/4 Kinase Activity across Human Cell Types , 2011, The Journal of Immunology.

[8]  G. Schreiber,et al.  Cytokine-receptor interactions as drug targets. , 2010, Current opinion in chemical biology.

[9]  A. Murasawa,et al.  Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. , 2010, Journal of periodontology.

[10]  R. Pope,et al.  The role of Toll-like receptors in rheumatoid arthritis , 2009, Current rheumatology reports.

[11]  Min Wu,et al.  A core-attachment based method to detect protein complexes in PPI networks , 2009, BMC Bioinformatics.

[12]  A. Prasse,et al.  Calgranulin B (S100A9) Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Diseases , 2008, Inflammation.

[13]  Chung-Yen Lin,et al.  Hubba: hub objects analyzer—a framework of interactome hubs identification for network biology , 2008, Nucleic Acids Res..

[14]  Reinhard Guthke,et al.  Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept , 2008, Arthritis research & therapy.

[15]  G. Herrero-Beaumont,et al.  Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[16]  T. Thalhamer,et al.  MAPKs and their relevance to arthritis and inflammation. , 2007, Rheumatology.

[17]  A. Barabasi,et al.  Human disease classification in the postgenomic era: A complex systems approach to human pathobiology , 2007, Molecular systems biology.

[18]  T. Wilhelm,et al.  Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts , 2007, Arthritis research & therapy.

[19]  Thomas Pap,et al.  Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis , 2005, Nature Clinical Practice Rheumatology.

[20]  R. Gay,et al.  RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. , 2005, Arthritis and rheumatism.

[21]  L. Joosten,et al.  The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. , 2005, Arthritis and rheumatism.

[22]  L. Joosten,et al.  Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways , 2005, Arthritis Research & Therapy.

[23]  F. Berenbaum,et al.  Signal transduction pathways: new targets for treating rheumatoid arthritis. , 2004, Joint, bone, spine : revue du rhumatisme.

[24]  G. Firestein,et al.  Rheumatoid arthritis: regulation of synovial inflammation. , 2004, The international journal of biochemistry & cell biology.

[25]  Michel L. Goldstein,et al.  Problems with fitting to the power-law distribution , 2004, cond-mat/0402322.

[26]  G. Firestein,et al.  Signal transduction networks in rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[27]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[28]  K. Zakrzewska,et al.  No association between human parvovirus B19 infection and Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.

[29]  Tsviya Olender,et al.  GeneCardsTM 2002: towards a complete, object-oriented, human gene compendium , 2002, Bioinform..

[30]  Y. Hayashizaki,et al.  T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation. , 2002, Biochemical and biophysical research communications.

[31]  N. Miyasaka,et al.  Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints. , 2001, The Journal of rheumatology.

[32]  Thomas Pap,et al.  Arthritis , 2000, Nature Biotechnology.

[33]  R. Medzhitov,et al.  The Toll-receptor family and control of innate immunity. , 1999, Current opinion in immunology.

[34]  S. K. Lee,et al.  Enhanced expression of immunoglobulin kappa light chains with unusually long CDR3 regions in patients with rheumatoid arthritis. , 1998, The Journal of rheumatology.

[35]  T. Rème,et al.  Growth factor activity of IL-6 in the synovial fluid of patients with rheumatoid arthritis. , 1994, Clinical and experimental rheumatology.

[36]  G. Pawelec,et al.  Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. , 1992, Annals of the rheumatic diseases.

[37]  G. Peters,et al.  Inactivating PSMB 5 Mutations and P-Glycoprotein ( Multidrug Resistance-Associated Protein / ATP-Binding Cassette B 1 ) Mediate Resistance to Proteasome Inhibitors : Ex Vivo Efficacy of ( Immuno ) Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis , 2012 .

[38]  Jing Gao,et al.  Integrating and annotating the interactome using the MiMI plugin for cytoscape , 2009, Bioinform..

[39]  Gary D Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.